VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.86%)
As of: Aug 21, 2026 · 3:59 PM EDT

VivoSim Labs (VIVS) Return on Sales (2011 - 2026)

VivoSim Labs (VIVS) posted quarterly Return on Sales of 0.79% for Q1 2026, down 27.0% year-over-year from 1.08% in Q1 2025, and up 28.92% quarter-over-quarter from 1.11% in Q4 2025.

VivoSim Labs (VIVS) Return on Sales (2011 - 2026) Analysis & Trends

VivoSim Labs' Return on Sales history runs 15 years deep, the most recent figure standing at 0.79% for Q1 2026.

  • In Q1 2026, Return on Sales fell 27.0% year-over-year to 0.79%; the TTM figure through Mar 2026 stood at 0.89% (down 3.0% YoY), while the FY2026 annual figure was 1.09%, down 2.0% from the prior year.
  • Return on Sales for Q1 2026 stood at 0.79%, up from 1.11% in the prior quarter.
  • The five-year high for Return on Sales was 0.01% in Q1 2022, with the low at 7.46% in Q4 2023.
  • The 5-year median for Return on Sales is 0.79% (2026), against an average of 1.07%.
  • The sharpest annual moves came in 2023 and 2024: Return on Sales plunged 721 bps in 2023, then jumped 597 bps in 2024.
  • VivoSim Labs' Return on Sales stood at 0.25% in 2022, then tumbled by 2883 bps to 7.46% in 2023, then surged by 80 bps to 1.49% in 2024, then gained by 25 bps to 1.11% in 2025, then grew by 29 bps to 0.79% in 2026.
  • Business Quant data shows VIVS's Return on Sales at 0.79% in Q1 2026, 1.11% in Q4 2025, and 0.96% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.00%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 0.00%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -0.05%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 0.00%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.00%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.00%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.00%
10 VivoSim Labs 1.49 Mn 1.49 Mn - -1.52%

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.70%
Mar 31, 2026 -0.79%
Dec 31, 2025 -1.11%
Sep 30, 2025 -0.96%
Jun 30, 2025 -0.80%
Mar 31, 2025 -0.52%
Dec 31, 2024 -1.49%
Sep 30, 2024 -0.91%
Jun 30, 2024 -0.89%
Mar 31, 2024 -0.97%
Dec 31, 2023 -7.46%
Sep 30, 2023 -0.52%
Jun 30, 2023 -0.56%
Mar 31, 2023 -0.46%
Dec 31, 2022 -0.25%
Sep 30, 2022 -0.45%
Jun 30, 2022 -0.09%
Mar 31, 2022 -0.01%
Sep 30, 2020 -0.67%
Jun 30, 2020 -0.12%